Key result
Biatrial Maze during mitral valve surgery yields ~71% freedom from AF over a decade.
Why the study?
Data on outcomes of combined Maze and mitral valve procedures beyond 10 years are limited.
Does concomitant modified Cox-Maze and mitral valve surgery provide long-term freedom from atrial fibrillation and improve survival in patients with mitral valve disease and permanent AF?
Cohort (n=406)
No
Does concomitant modified Cox-Maze and mitral valve surgery provide long-term freedom from atrial fibrillation and improve survival in patients with mitral valve disease and permanent AF?
Concomitant modified Cox-Maze and mitral valve surgery provides durable long-term freedom from atrial fibrillation, which is associated with a significant reduction in neurological complications.
Answers are grounded in this paper and cite their sources.
Durable AF freedom after concomitant Maze-mitral surgery supports consideration in selected patients; leaves open randomized confirmation of survival benefit.
PURPOSE: There are limited data on outcomes of combined Maze and mitral valve procedures beyond 10 years. This study analyzed the efficacy of this operation. METHODS: Between June 2004 and December 2022, 406 patients underwent mitral surgery concomitant with Maze procedure were evaluated. Rhythm outcomes, predictors of recurrence, and survival were assessed. RESULTS: The median follow-up period was 100 months. Rheumatic disease was present in 58%. Mitral valve repair was performed in 57.1%. Freedom from atrial fibrillation (AF) at 5, 10, and 15 years was 82.5%, 70.8%, and 52.7%, respectively. Overall survival rates were not different between patients in sinus rhythm (SR) and those who remained in AF (p = 0.172). However, patients in SR experienced fewer neurological complication (p = 0.001). Predictors of AF recurrence included preoperative AF duration (p = 0.005), left atrial diameter (LAD) >50 mm (p <0.001), concomitant tricuspid valve surgery (p = 0.049), and the presence of AF on postoperative day 7 (p <0.001). Factors influencing survival were age >60 years (p <0.001) and a postoperative left ventricular ejection fraction <40% (p <0.001). CONCLUSIONS: The combined Maze and mitral valve surgery provides significant benefits in managing AF with mitral disease. Predictors of recurrence included AF duration, LAD size >50 mm, associated tricuspid valve disease, and AF on day 7. SR patients had fewer neurological complications.
No takes yet. Share an insight, caveat, or question.
Kasemsarn et al. (2025) conducted a cohort in Mitral valve disease with permanent atrial fibrillation (n=406). Concomitant modified biatrial Maze and mitral valve surgery was evaluated on Freedom from atrial fibrillation at 10 years. Concomitant modified biatrial Maze and mitral valve surgery achieved freedom from atrial fibrillation in 82.5%, 70.8%, and 52.7% of patients at 5, 10, and 15 years, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: